The Investment Column: British Biotech
Friday 19 November 1999
But the future still looks risky for British Biotech, if less so than previously. The company yesterday warned that crucial trial data for Marimastat in pancreatic cancer would be delayed a few weeks, and is due by February now.
Fortunately, this is for logistical reasons only, but the shares fell 8 per cent on the news. On the upside, a cost-reduction programme is nearly complete. Cash burn in the half year lessened from pounds 17m to pounds 12m, while pre-tax losses narrowed to pounds 11.4m from pounds 16.6m. The group still has pounds 86m of cash in its coffers.
While a partnership deal with Schering-Plough of the US is a vote of confidence in Marimastat, British Biotech is not relying on the drug.
It is in talks to acquire up to five new products, either through licensing deals or through straightforward acquisitions. Until news of these breaks, the shares, at 28.5p, are highly speculative.
- 1 Labour rallies behind Flint as deputy leader to offset a Corbyn win
- 2 Katie Hopkins reveals fear she will die during brain surgery to cure epilepsy
- 3 The difference between a psychopath and a sociopath
- 4 Dutch King Willem-Alexander declares the end of the welfare state
- 5 'Cool kids' can go on to become losers in later life, study finds
Yvette Cooper: Our choice is years of Tory rule under Jeremy Corbyn – or a return to a Labour government
Is Britain really full up? Are migrants taking our jobs? Leading academic answers the most common anti-immigration claims
Calais Migrant Crisis: Deputy Mayor of Calais labels Cameron's use of 'swarm' as 'racist' and 'ignorant'
While we fixate on Calais, the Home Office is quietly deporting dozens of migrants on 'ghost flights'
Calais crisis: The seven claims made about the migrants - and the reality
Calais crisis: For desperate migrants it is 'England or death' as they brave dogs, riot police and speeding trains
iJobs Money & Business
£30000 - £35000 per annum: Recruitment Genius: This is an exciting opportunity...
£13000 - £15000 per annum: Recruitment Genius: Are you passionate about custom...
£22000 - £25000 per annum: Recruitment Genius: Main purpose: Under the directi...
£35000 - £37000 per annum + benefits : Ashdown Group: Contracts Manager - City...